In Situ Hybridization Market – Growth In R&D Expenditure Will Result In Surge In Global Revenue
Summary
- IN SITU HYBRIDIZATION MARKET OVERVIEW.
- Untapped markets in developing countries.
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global in situ hybridization market.
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the ISH market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Recent Developments in the Industry:
# In 2020, RNAscope ISH Detection Kit (Bio-Techne) received CE-IVD approval for BOND-III platform (Leica Biosystems )
# In 2020, Creative Bioarray (US) launched 2019 Novel Coronavirus Detection FISH probes to detect viral particles in infected cells & tissues.
# In 2019, Roche launched VENTANA HER2 Dual ISH DNA Probe Cocktail assay
# In 2019, Roche provided its platform for integration with Bio-Techne’s RNAscope ISH assay.
# In 2019, Agilent Technologies, the National University of Singapore, and the National University Hospital set up Singapore’s first integrated R&D facility.
What the Market Looks Like?
The global in situ hybridization market size is projected to reach USD 1.3 billion by 2025 from USD 0.9 billion in 2020, at a CAGR of 7.4% during the forecast period.
Download PDF Brochure @Download PDF Brochure - In Situ Hybridization Market - Global Forecast to 2025 | MarketsandMarkets
Global Geographical Scenario:
North America accounted for the largest share of the ISH market
North America accounted for the largest share of the global market, followed by Europe. The large share of the North American region can be attributed to the presence of major players operating in the ISH market in the US, the rising incidence of cancer and infectious diseases, and the increasing adoption of CDx assay kits.
What Drives the Market?
The increasing incidence of cancer and genetic disorder and awareness of ISH based companion diagnostics tests are the major factors driving the growth of this market.
Market Size Estimation:
The global size of the ISH market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the global ISH market and other dependent submarkets.. The research methodology and the market numbers were then validated from primaries.
Data Triangulation:
After arriving at the overall market size, from the market size estimation process explained above, the ISH market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable.
Feel FREE to Connect to Our Research Experts for More Detailed Information@ In Situ Hybridization Market
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.